Alhajaji Raghad, Alfahmi Manal, Alamri Sadin Ayman, Alamri Aseel Ayman, Al Sulaiman Khalid, Alsugair Sulaiman Ibrahim, Alsulimani Hadeel Adel
Makkah Branch of Ministry of Health, Saudi Ministry of Health, Makkah, Saudi Arabia.
Sleep Medicine Fellowship, King Saud University Medical City, Riyadh, Saudi Arabia.
Eur J Med Res. 2025 Aug 5;30(1):710. doi: 10.1186/s40001-025-02926-4.
Meningococcal meningitis (MM), which is caused by the bacterium Neisseria meningitidis, represents a considerable public health concern during the Hajj and Umrah pilgrimages. The mass gathering and close quarters associated with these events create an environment that enhances the transmission of this potentially life-threatening infection. Despite mandatory vaccination policies, concerns persist regarding carriage rates and the potential for outbreaks, which are heightened by several factors. This systematic review and single-arm meta-analysis aimed to evaluate the carriage of Neisseria meningitidis (NM) and its vaccination status among pilgrims.
A systematic review and meta-analysis were conducted according to PRISMA guidelines, focusing on Muslim pilgrims of any nationality who participated in the mass gatherings of Hajj or Umrah in Makkah, Saudi Arabia. We performed a comprehensive search of four electronic databases (PubMed, Scopus, Web of Science, and Cochrane Central Register of Controlled Trials) from their inception to April 2024. Eligible studies reported on N. meningitidis carriage prevalence, serogroups, and vaccination status among Hajj and Umrah pilgrims. The primary outcome measured was the overall carriage prevalence of Neisseria meningitidis, as determined by the time of assessment. Data were synthesized using random-effects models.
Out of the 417 studies initially screened, 21 studies (23,552 participants) were included in the systematic review; while the meta-analysis consisted of nine studies. The carriage prevalence of NM before Hajj was 1.6%, increasing to 3.4% after Hajj. Prior to Hajj, the estimate of serogroup A and W was recorded at 0.003 (95% CI [-0.001, 0.006]) and 0.068; (95% CI [-0.14, 0.15]), respectively. Following Hajj, the estimate shifted to 0.001 (95% CI [0.000, 0.002]) for serogroup A and 0.072; 95% CI [0.037, 0.108]) for serogroup W. Vaccination status varied, with gaps among domestic pilgrims, along with the presence of ciprofloxacin resistance in certain strains.
Saudi Arabia's commendable and sustained commitment to proactive prevention strategies during Hajj and Umrah has reduced Neisseria meningitis cases. Nonetheless, carriage variability and rising antimicrobial resistance of Neisseria meningitidis highlight the need for enhanced surveillance and alternative prophylaxis strategies for high-risk populations. The findings of this study remain inconclusive due to significant heterogeneity and underscore the need for comprehensive and well-structured primary studies to gather strong evidence.
脑膜炎球菌性脑膜炎(MM)由脑膜炎奈瑟菌引起,在朝觐和副朝期间是一个重大的公共卫生问题。与这些活动相关的大规模聚集和人员密集创造了一个有利于这种潜在危及生命的感染传播的环境。尽管有强制疫苗接种政策,但由于多种因素,人们对携带率和爆发可能性的担忧依然存在。本系统评价和单臂荟萃分析旨在评估朝觐者中脑膜炎奈瑟菌(NM)的携带情况及其疫苗接种状况。
根据PRISMA指南进行系统评价和荟萃分析,重点关注参与沙特阿拉伯麦加朝觐或副朝大规模聚集活动的任何国籍的穆斯林朝觐者。我们对四个电子数据库(PubMed、Scopus、科学网和Cochrane对照试验中央注册库)从创建到2024年4月进行了全面检索。符合条件的研究报告了朝觐和副朝朝觐者中脑膜炎奈瑟菌的携带率、血清群和疫苗接种状况。测量的主要结果是根据评估时间确定的脑膜炎奈瑟菌总体携带率。数据使用随机效应模型进行综合分析。
在最初筛选的417项研究中,21项研究(23552名参与者)被纳入系统评价;而荟萃分析包括9项研究。朝觐前NM的携带率为1.6%,朝觐后升至3.4%。朝觐前,A群和W群血清型的估计值分别为0.003(95%CI[-0.001,0.006])和0.068(95%CI[-0.14,0.15])。朝觐后,A群血清型的估计值变为0.001(95%CI[0.000,0.002]),W群血清型的估计值变为0.072(95%CI[0.037,0.108])。疫苗接种状况各不相同,国内朝觐者之间存在差距,并且某些菌株存在环丙沙星耐药性。
沙特阿拉伯在朝觐和副朝期间对积极预防策略的值得称赞且持续的承诺减少了脑膜炎奈瑟菌病例。尽管如此,脑膜炎奈瑟菌的携带情况变化以及抗菌耐药性上升凸显了加强对高危人群监测和采用替代预防策略的必要性。由于显著的异质性,本研究结果尚无定论,并强调需要进行全面且结构良好的初步研究以收集有力证据。